ProUroCare Medical has submitted an application to the FDA seeking approval for a device that can generate 3-D images of the prostate gland to track prostate cancer. The startup firm said its technology quantifies tissue elasticity to enable physicians to conduct preliminary biopsies and monitor cancer progression.

Related Summaries